Can-Fite BioPharma Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $6.0M | $8.1M |
| FY2017 | — | $3.0M | $3.5M |
| FY2018 | — | $3.0M | $3.6M |
| FY2019 | — | $2.4M | $2.7M |
| FY2020 | — | $6.1M | $8.3M |
| FY2021 | — | $14.4M | $4.4M |
| FY2022 | — | $4.5M | $3.0M |
| FY2023 | — | $6.2M | $4.3M |
| FY2024 | — | $5.4M | $4.8M |
| FY2025 | — | $5.6M | $5.5M |